Amlodipine vs amlodipine besylate pharmacology
Pro Research Analysisby 
Searched over 200M research papers
Amlodipine vs Amlodipine Besylate: Pharmacology and Salt Formulation Keywords
Pharmacokinetic Equivalence of Amlodipine Salts
Amlodipine is a calcium channel blocker commonly used to treat hypertension and angina, and it is most often prescribed as amlodipine besylate. Studies comparing amlodipine besylate with other salt forms, such as amlodipine maleate and amlodipine nicotinate, have consistently shown that these different salts have nearly identical pharmacokinetic profiles. Key parameters like area under the curve (AUC), peak plasma concentration (Cmax), and time to peak concentration (Tmax) are not significantly different between the salts, indicating that the rate and extent of amlodipine absorption are similar regardless of the salt form used 1234.
Pharmacodynamic Effects and Clinical Interchangeability
The pharmacodynamic effects—such as reductions in systolic and diastolic blood pressure and changes in pulse rate—are also similar between amlodipine besylate and other amlodipine salts. No significant differences in blood pressure lowering or heart rate effects have been observed in healthy volunteers, supporting the clinical interchangeability of these formulations 134.
Bioequivalence and Safety Profiles
Bioequivalence studies confirm that amlodipine besylate and other salts like amlodipine maleate meet regulatory criteria for bioequivalence, both in fasting and fed conditions. Both generic and original formulations of amlodipine besylate, as well as alternative salts, are well tolerated with no significant differences in safety profiles or adverse events reported 2456.
Physicochemical and Pharmacological Properties of Amlodipine Besylate
Amlodipine besylate is a second-generation dihydropyridine calcium channel blocker that is highly selective for arterial vascular smooth muscle over cardiac tissue. It is effective in reducing blood pressure and angina symptoms, and it also has beneficial effects on catecholamine levels and calcium deposition in the heart, with a negative inotropic effect that reduces cardiac workload . These pharmacological properties are inherent to the amlodipine molecule itself and are not significantly altered by the choice of salt form.
Conclusion
In summary, amlodipine besylate and other amlodipine salts (such as maleate and nicotinate) have equivalent pharmacokinetic and pharmacodynamic profiles, similar safety, and can be used interchangeably in clinical practice. The therapeutic effects and tolerability are determined by the amlodipine molecule, not the specific salt form, making all these formulations effective options for managing hypertension and angina 1234567.
Sources and full results
Most relevant research papers on this topic